Names | |
---|---|
IUPAC name
1-methyl-3-nitro-1-nitrosoguanidine
|
|
Other names
N-Methyl-N-nitroso-N′-nitroguanidine; N-Methyl-N′-nitro-N-nitrosoguanidine
|
|
Identifiers | |
70-25-7 | |
3D model (Jmol) | Interactive image |
Abbreviations | MNNG |
ChemSpider | 6025 |
ECHA InfoCard | 100.000.664 |
KEGG | C14592 |
PubChem | 6261 |
|
|
|
|
Properties | |
C2H5N5O3 | |
Molar mass | 147.09 g/mol |
Appearance | Yellow crystals |
Melting point | 118 °C (244 °F; 391 K) (decomposes) |
reacts violently, slowly hydrolysed | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Methylnitronitrosoguanidine (MNNG or MNG) is a biochemical tool used experimentally as a carcinogen and mutagen. It acts by adding alkyl groups to the O6 of guanine and O4 of thymine, which can lead to transition mutations between GC and AT. These changes do not cause a heavy distortion in the double helix of DNA and thus are hard to detect by the DNA mismatch repair system.
In organic chemistry, MNNG is used as a source of diazomethane when reacted with aqueous potassium hydroxide.
MNNG is a probable human carcinogen listed as an IARC Group 2A carcinogen.